Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2014 05:44 ET | Source: Bionor Pharma

UPDATE: Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Well Tolerated and Increases CD4 Counts in People Living With HIV

OSLO, NORWAY--(Marketwired - Nov 18, 2014) - Bionor Pharma ASA (OSLO: BIONOR) Treatment with Vacc-4x + Revlimid (lenalidomide) was well tolerated ...
November 17, 2014 08:01 ET | Source: Bionor Pharma

Bionor Pharma Announces That the Combination of Vacc-4x + Revlimid(R) Is Safe and Increases CD4 Counts in People Living With HIV

OSLO, NORWAY--(Marketwired - Nov 17, 2014) - Bionor Pharma ASA (OSLO: BIONOR) Treatment with Vacc-4x + Revlimid (lenalidomide) was safe and well tolerated ...
February 11, 2014 09:27 ET | Source: Bionor Pharma

Bionor Pharma's Phase II Vacc-4x Data Published in the Lancet Infectious Diseases

OSLO, NORWAY--(Marketwired - Feb 11, 2014) - Bionor Pharma ASA (OSE: BIONOR) announces that the results from the randomized, multicenter, double-blinded, placebo-controlled Phase II trial with 135...
November 04, 2013 16:00 ET | Source: The Blue Ribbon Commission for the Advancement of Osteopathic Medical Education

Overhaul of Medical Education to Address Primary Care Physician Shortage Recommended by National Panel

WASHINGTON, DC--(Marketwired - Nov 4, 2013) - News Summary: A Blue Ribbon Commission of medical education leaders has published in a report in the November issue of Health Affairs...
October 23, 2013 15:10 ET | Source: American Association of Colleges of Osteopathic Medicine

MULTIMEDIA UPDATE: Experts: Steep Increase in Osteopathic Medical College Enrollment May Help Mitigate National Physician Workforce Shortage

WASHINGTON, DC--(Marketwired - Oct 23, 2013) - Osteopathic medical college new student enrollment grew by 11.1 percent this year, according to data released by the American Association of Colleges...
October 23, 2013 14:18 ET | Source: American Association of Colleges of Osteopathic Medicine

Experts: Steep Increase in Osteopathic Medical College Enrollment May Help Mitigate National Physician Workforce Shortage

WASHINGTON, DC--(Marketwired - Oct 23, 2013) - Osteopathic medical college new student enrollment grew by 11.1 percent this year, according to data released by the American Association of Colleges...
June 05, 2013 08:00 ET | Source: Vestiq Pharmaceuticals

Vestiq Pharmaceuticals Offers MagBID ER Magnesium Dietary Supplement for Patients Who Have Lost Magnesium Because of Illness or Treatment With Certain Medicines

MORRISVILLE, NC--(Marketwired - Jun 5, 2013) - Vestiq Pharmaceuticals, Inc. today announced that it will add MagBID ER (magnesium L-lactate dehydrate) tablets to its growing list of supportive...
February 05, 2013 08:00 ET | Source: Vestiq Pharmaceuticals

Vestiq Pharmaceuticals Enters Into Exclusive Distribution Agreement With BMG Pharma S.r.l. for GelX(R)* Oral Gel Treatment of Oral Mucositis

MORRISVILLE, NC--(Marketwire - Feb 5, 2013) - Vestiq Pharmaceuticals, Inc. today announced that it has taken the rights for distribution of GelX Oral Gel from BMG Pharma S.r.l. GelX is an oral...
January 16, 2013 08:00 ET | Source: Vestiq Pharmaceuticals

Vestiq Pharmaceuticals, Inc. Launches With Agenda for Rapid Growth, Acquires NDAs for ORAVIG(R) (Miconazole Buccal Tablets) and Zuplenz(R) (Ondansetron) Oral Soluble Film

MORRISVILLE, NC--(Marketwire - Jan 16, 2013) - Vestiq Pharmaceuticals, an emerging Specialty Pharmaceutical Company, formally announces its launch of products that began commercialization in...
October 15, 2012 08:00 ET | Source: Laurantis Pharma Oy; Ark Therapeutics Group plc

Laurantis Pharma and Ark Therapeutics Sign Manufacturing Agreement for Production of Lymfactin(TM) Investigational Treatment for Breast Cancer-Associated Lymphedema

LONDON and TURKU, FINLAND--(Marketwire - Oct 15, 2012) - Ark Therapeutics has been selected to manufacture and supply Lymfactin™ to Laurantis Pharma under a conditional agreement...

Next Page keyboard_arrow_right